Friday, March 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – April 30, 2017

by Global Biodefense Staff
April 30, 2017
Biological Defense Headlines of the Week

Biological Defense Headlines of the WeekSee what we’re reading this week at Global Biodefense on topics including the current state of pandemic preparedness, investing in animal health systems, and the yellow fever vaccine shortage.

BIOPREPAREDNESS

  • Why are we more at risk than ever for a global pandemic? (Contagion Live)
  • U.S. Preparedness Index points to scattered and mediocre progress (Pandora Report)
  • The world needs a DARPA-style project to prevent pandemics (HBR)
  • The current state of biodefense in the US (Global Risk Research Network)
  • Pandemic preparedness in the homeless sector (Cambridge.org)
  • New CDC guidelines on flu pandemic measures reflect 2009 lessons (CIDRAP)

POLICY, PRACTICES & POLITICS

  • USDA announces 4.8M available to support food safety outreach program (EurekAlert)
  • Community mitigation guidelines to prevent pandemic influenza (CDC)
  • Viewpoints: keep investing in animal health system (Philly.com)

SELECT AGENTS

  • 80-year-old ‘viable’ anthrax strain debunked using advanced genomic sequencing (R&D)
  • B. anthracis edema toxin increases fractional free water and sodium reabsorption (ASM)
  • Ricin to the challenge: Bid with vaccine excites Street (Soligenix)
  • Unexpected relations of historical anthrax strain (mBio)

MEDICAL COUNTERMEASURES

  • Advancing new vaccines against pandemic flu in low-resource countries (Vaccine)
  • U.S. top court debates making copycat biologics available sooner (Reuters)
  • WHO vaccine advisors weigh in on polio, cholera, Ebola, diphtheria (CIDRAP)
  • Maximizing the impact of inactivated polio vaccines (The Lancet)
  • Army rejects request to deny Sanofi an exclusive license for a Zika vaccine (STAT News)
  • Flexible, highly potent and effective adjuvant for pandemic influenza vaccines (NCBI)
  • Immunoglobulin infusion as therapy against influenza? (Science Direct)
  • Forge Therapeutics antibiotics program scores 15M in venture funding (C&EN)
  • Only weeks remain for US supply of yellow fever vaccine (CIDRAP)

OUTBREAK NEWS & THREAT SURVEILLANCE

  • Meningitis outbreak in Nigeria has killed 813 people – minister (Reuters)
  • Campy, salmonella caused most bacterial foodborne illnesses in 2016 (OH&S)
  • FDA resource page on Zika virus diagnostic development (FDA.gov)
  • Zika in Africa—the invisible epidemic? (The Lancet)

RESEARCH & TECH

  • Quick, sensitive diagnostic tests with CRISPR (NIH)
  • Zika virus persists in the nervous system and elsewhere (The Scientist)
  • Flow cytometry advances in the clinical and military arenas (MLO)
  • Pathogen-specific cargo delivery platform based on mesoporous silica nanoparticles (JACS)
  • Managing disease spread through accessible modeling (Newswise)
  • Atomic-level motion may drive bacteria’s ability to evade immune system (ScienMag)

SPECIAL INTEREST + HISTORICAL

  • NBAF update: the lab as a buffer against catastrophic outbreaks (The Mercury)
  • Applications sought for National Preparedness and Response Science Board (FR)
  • Plague and Contagion in the Islamic Mediterranean (Google Books)

Related Posts

News Scan

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC